rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ram Mukunda

CEO

Company insider

Files Form 4 as: CEO, IGC Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
147
Buys
1
Sells
13
Bought
$0
Sold
$805K
Companies
1
Companies where not an officer
0
First trade
13 May 2009
Last trade
25 Sep 2026
Last filed
29 Sep 2026

Companies traded

Where they are an officer
IGC IGC PharmaDirector, Officer, 10% owner · Biotechnology · last 25 Sep 20261 buy · 13 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
25 Sep 2026filed 29 Sep 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code G—100,000 at $0.00filing
25 Sep 2026filed 29 Sep 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code G—100,000 at $0.00filing
25 Sep 2026filed 29 Sep 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code G—100,000 at $0.00filing
25 Sep 2026filed 29 Sep 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code G—100,000 at $0.00filing
30 Jun 2026filed 1 Jul 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code A$601K2,226,475 at $0.27filing
30 Jun 2026filed 1 Jul 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code A$601K2,226,475 at $0.27filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M—333,333 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M$84K323,077 at $0.26filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—333,333 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—323,077 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—33,332 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M—33,332 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—333,333 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—323,077 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—16,667 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—33,332 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M—333,333 at $0.00filing
1 Apr 2026filed 6 Apr 2026IGC IGC PharmaBiotechnologySEC FORM 4 Code M$84K323,077 at $0.26filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care14

Buys in green, sells in red, by the company’s sector.

Related people

Claudia GrimaldiPfo · Pfo at IGC Pharma, filing Form 4 there in the last year
Richard K. PrinsDirector · Director at IGC Pharma, filing Form 4 there in the last year
James P. MoranDirector · Director at IGC Pharma, filing Form 4 there in the last year